Sézary syndrome managed with histone deacetylase inhibitor followed by anti‐CCR4 monoclonal antibody
T. Numata; T. Nagatani; K. Shirai; T. Maeda; K. Mae; M. Nakasu; M. Saito; T. Usuda; R. Tsuboi; Y. Okubo
Author Information: Department of Dermatology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.